Shionogi wins US approval for first pill to prevent Covid following exposure

June 1, 2026 12:50 PM EDT FDA+ Sh­iono­gi wins US ap­proval for first pill to pre­vent Covid fol­low­ing ex­po­sure Zachary Brennan Senior Editor Japan’s Sh­iono­gi on Mon­day said it won FDA ap­proval for its oral an­tivi­ral to pre­vent Covid‑19 in adults and chil­dren old­er … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER